EdgarLookup

UNITEDHEALTH GROUP INC — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that UNITEDHEALTH GROUP INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Revenue — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $113.16B Oct 28, 2025
Q2 2025 Jun 30, 2025 $111.62B Aug 11, 2025
Q1 2025 Mar 31, 2025 $109.58B May 7, 2025
Q3 2025 Sep 30, 2024 $100.82B Oct 28, 2025
Q2 2025 Jun 30, 2024 $98.86B Aug 11, 2025
Q1 2025 Mar 31, 2024 $99.80B May 7, 2025
Q3 2024 Sep 30, 2023 $92.36B Nov 4, 2024
Q2 2024 Jun 30, 2023 $92.90B Aug 9, 2024
Q1 2024 Mar 31, 2023 $91.93B May 9, 2024
Q3 2023 Sep 30, 2022 $80.89B Nov 6, 2023
Q2 2023 Jun 30, 2022 $80.33B Aug 2, 2023
Q1 2023 Mar 31, 2022 $80.15B May 3, 2023
Q3 2022 Sep 30, 2021 $72.34B Nov 2, 2022
Q2 2022 Jun 30, 2021 $71.32B Aug 3, 2022
Q1 2022 Mar 31, 2021 $70.20B May 4, 2022
Q3 2021 Sep 30, 2020 $65.12B Nov 3, 2021
Q2 2021 Jun 30, 2020 $62.14B Aug 3, 2021
Q1 2021 Mar 31, 2020 $64.42B May 5, 2021
Q3 2020 Sep 30, 2019 $60.35B Nov 2, 2020
Q2 2020 Jun 30, 2019 $60.60B Aug 3, 2020

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $2.35B Oct 28, 2025
Q2 2025 Jun 30, 2025 $3.41B Aug 11, 2025
Q1 2025 Mar 31, 2025 $6.29B May 7, 2025
Q3 2025 Sep 30, 2024 $6.06B Oct 28, 2025
Q2 2025 Jun 30, 2024 $4.22B Aug 11, 2025
Q1 2025 Mar 31, 2024 ($1.41B) May 7, 2025
Q3 2024 Sep 30, 2023 $5.84B Nov 4, 2024
Q2 2024 Jun 30, 2023 $5.47B Aug 9, 2024
Q1 2024 Mar 31, 2023 $5.61B May 9, 2024
Q3 2023 Sep 30, 2022 $5.26B Nov 6, 2023
Q2 2023 Jun 30, 2022 $5.07B Aug 2, 2023
Q1 2023 Mar 31, 2022 $5.03B May 3, 2023
Q3 2022 Sep 30, 2021 $4.09B Nov 2, 2022
Q2 2022 Jun 30, 2021 $4.27B Aug 3, 2022
Q1 2022 Mar 31, 2021 $4.86B May 4, 2022
Q3 2021 Sep 30, 2020 $3.17B Nov 3, 2021
Q2 2021 Jun 30, 2020 $6.64B Aug 3, 2021
Q1 2021 Mar 31, 2020 $3.38B May 5, 2021
Q3 2020 Sep 30, 2019 $3.54B Nov 2, 2020
Q2 2020 Jun 30, 2019 $3.29B Aug 3, 2020

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $4.32B Oct 28, 2025
Q2 2025 Jun 30, 2025 $5.15B Aug 11, 2025
Q1 2025 Mar 31, 2025 $9.12B May 7, 2025
Q3 2025 Sep 30, 2024 $8.71B Oct 28, 2025
Q2 2025 Jun 30, 2024 $7.88B Aug 11, 2025
Q1 2025 Mar 31, 2024 $7.93B May 7, 2025
Q3 2024 Sep 30, 2023 $8.53B Nov 4, 2024
Q2 2024 Jun 30, 2023 $8.06B Aug 9, 2024
Q1 2024 Mar 31, 2023 $8.09B May 9, 2024
Q3 2023 Sep 30, 2022 $7.46B Nov 6, 2023
Q2 2023 Jun 30, 2022 $7.13B Aug 2, 2023
Q1 2023 Mar 31, 2022 $6.95B May 3, 2023
Q3 2022 Sep 30, 2021 $5.71B Nov 2, 2022
Q2 2022 Jun 30, 2021 $5.98B Aug 3, 2022
Q1 2022 Mar 31, 2021 $6.74B May 4, 2022
Q3 2021 Sep 30, 2020 $4.65B Nov 3, 2021
Q2 2021 Jun 30, 2020 $9.24B Aug 3, 2021
Q1 2021 Mar 31, 2020 $5.00B May 5, 2021
Q3 2020 Sep 30, 2019 $5.01B Nov 2, 2020
Q2 2020 Jun 30, 2019 $4.74B Aug 3, 2020